3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Triple Negative Breast Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Ganglioneuroblastoma
2
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Adenoma, Islet Cell
1
Interventions
daratumumab
4
Lenalidomide
3
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Dexamethasone
2
Curcumin
2
Calcium Dobesilate
2
piperine
1
isatuximab
1
iberdomide
1
Watchful Waiting
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Melphalan
1
Leflunomide
1
IPH-2101
1
Dietary Fiber
1
Diet, Mediterranean
1
Cholestyramine Resin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
sargramostim
×
90 days
×
Clear all
No trials found.